Afshin Emre Kayipmaz, a member of the Scientific Council on Coronavirus under the Turkish Ministry of Health, told RIA Novosti that while only tests of the Russian drug Sputnik V are underway, it is too early to talk about the approval of the vaccine on the territory of the state.
The announcement of Turkey’s approval of the Sputnik V vaccine had previously appeared on the Yeni Safak website. The newspaper referred to the words of Kayipmaz.
In an interview with RIA Novosti, a representative of the Scientific Council on Coronavirus said that he had not told the reporter about the approval of the drug.
“I told the journalist that the Russian vaccine is being tested in Turkey, and only some of their stages have received intermediate positive results. I didn’t say anything else. Apparently, the journalist did not quite understand correctly, “Kayipmaz suggested, adding that he had already called the newspaper and asked to remove the information from the site.
The fact that media reports about the approval of the production of a Russian vaccine in Turkey are not true was confirmed by RIA Novosti and a representative of the Turkish Ministry of Health. He also stressed that testing of the drug continues as usual, but the final approval has not yet been received.
It should be noted that by 10.10 Moscow time the material on the approval of the Russian drug in Turkey had already been removed from the Yeni Safak website.
Earlier it was reported that the start of negotiations with the Russian Federation on the purchase of “Sputnik V” was announced
The Russian Sputnik V vaccine has been registered in 60 countries with a total population of over 1.5 billion people. Since March 4, the drug is undergoing an examination procedure at the European Medicines Agency (EMA), which is engaged in the approval of drugs for use on the European market.